We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.07%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$517M
AUM Growth
+$9.2M
(+1.8%)
Cap. Flow
+$14.4M
Cap. Flow
% of AUM
2.78%
Top 10 Holdings %
Top 10 Hldgs %
25.19%
Holding
131
New
22
Increased
34
Reduced
42
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$8.5M |
| 2 |
Option Care Health
OPCH
|
+$8.49M |
| 3 |
Prothena Corp
PRTA
|
+$6.75M |
| 4 |
Alignment Healthcare
ALHC
|
+$6.68M |
| 5 |
Evolent Health
EVH
|
+$6.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$8.62M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.28M |
| 3 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
+$6.42M |
| 4 |
Inspire Medical Systems
INSP
|
+$5.03M |
| 5 |
SGFY
Signify Health, Inc.
SGFY
|
+$4.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.31% |
| 2 | Industrials | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
ARS Pharmaceuticals
SPRY
$509M
| $6.67M | 1.29% |
782,410
-262,824
| -25% | -$1.71M |
|
27
Pfizer
PFE
$143B
| $6.63M | 1.28% |
129,400
| – | – |
|
|
ITCI
28
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.48M | 1.25% |
122,450
| – | – |
|
|
29
Alignment Healthcare
ALHC
$3.07B
| $6.46M | 1.25% |
+549,000
| New | +$6.68M |
|
|
FOLD
30
DELISTED
Amicus Therapeutics
FOLD
| $6.2M | 1.2% |
507,682
-65,000
| -11% | -$732K |
|
31
Travere Therapeutics
TVTX
$5.2B
| $6.15M | 1.19% |
292,320
+42,620
| +17% | +$903K |
|
32
Merck
MRK
$322B
| $6.1M | 1.18% |
55,000
-2,750
| -5% | -$281K |
|
33
Alkermes
ALKS
$8.22B
| $6.06M | 1.17% |
231,900
-500
| -0.2% | -$12K |
|
34
AbbVie
ABBV
$443B
| $6.03M | 1.17% |
37,300
-15,750
| -30% | -$2.41M |
|
|
CTIC
35
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $5.89M | 1.14% |
980,300
+12,000
| +1% | +$65.5K |
|
36
Amylyx Pharmaceuticals
AMLX
$2.26B
| $5.84M | 1.13% |
157,950
-47,450
| -23% | -$1.68M |
|
37
Altimmune
ALT
$552M
| $5.63M | 1.09% |
342,500
+73,400
| +27% | +$824K |
|
38
RadNet
RDNT
$5.02B
| $5.59M | 1.08% |
+296,933
| New | +$5.55M |
|
|
BLU
39
DELISTED
BELLUS Health Inc.
BLU
| $5.5M | 1.06% |
669,029
+54,600
| +9% | +$509K |
|
|
AXNX
40
DELISTED
Axonics, Inc. Common Stock
AXNX
| $5.48M | 1.06% |
87,646
-26,650
| -23% | -$1.77M |
|
41
Alnylam Pharmaceuticals
ALNY
$27.5B
| $5.42M | 1.05% |
22,810
+130
| +0.6% | +$27.7K |
|
42
Replimune Group
REPL
$941M
| $5.34M | 1.03% |
+196,500
| New | +$4.08M |
|
43
Boston Scientific
BSX
$69.5B
| $5.27M | 1.02% |
113,976
-13,000
| -10% | -$563K |
|
|
SGEN
44
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.16M | 1% |
40,190
+15,520
| +63% | +$2M |
|
|
BPMC
45
DELISTED
Blueprint Medicines
BPMC
| $5.08M | 0.98% |
115,900
+6,000
| +5% | +$288K |
|
46
Tenet Healthcare
THC
$20.5B
| $4.95M | 0.96% |
101,500
| – | – |
|
47
Arcus Biosciences
RCUS
$3.55B
| $4.93M | 0.95% |
238,482
+11,450
| +5% | +$315K |
|
48
Amgen
AMGN
$208B
| $4.71M | 0.91% |
17,920
+1,700
| +10% | +$456K |
|
|
49
Inspire Medical Systems
INSP
$1.45B
| $4.58M | 0.89% |
18,200
-23,600
| -56% | -$5.03M |
|
|
SILK
50
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $4.47M | 0.87% |
84,589
-29,411
| -26% | -$1.43M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Sectoral Asset Management held 131 positions worth $517M, up 1.8% from $508M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Sectoral Asset Management's Q4 2022 filing shows 22 new, 34 increased, 42 reduced and 11 closed positions. Its largest new stake was Option Care Health: 273,500 shares worth $8.23M. The largest sale was Syneos Health, Inc. Class A Common Stock, an estimated $8.62M.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 96% a quarter earlier, followed by Industrials.
- Sectoral Asset Management's largest Q4 2022 buy was Option Care Health: 273,500 shares worth $8.23M.
- Sectoral Asset Management added most to R1 RCM Inc. Common Stock in Q4 2022, an estimated $8.5M increase.
- Sectoral Asset Management's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $7.28M.
- Sectoral Asset Management fully exited Syneos Health, Inc. Class A Common Stock in Q4 2022, selling an estimated $8.62M.
- Sectoral Asset Management's ten largest holdings make up 25% of its $517M portfolio in Q4 2022.
- Sectoral Asset Management opened 22 new positions and closed 11 in Q4 2022.
- Sectoral Asset Management's portfolio value rose 1.8% quarter-over-quarter to $517M.
Based on Sectoral Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.